| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5824413 | Clinical Therapeutics | 2016 | 10 Pages |
Abstract
This study indicated that gem-IMRT or gem-SBRT in locally advanced pancreatic cancer is not cost-effective at a willingness to pay as defined by World Health Organization guideline in Taiwan.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Henry W.C. MD, MBA, Agnes L.F. PhD, MAMM, BScPharm, Chih-Hsin MD,